Strong Jobs Report Lifts Fed Hike Odds as Crypto Proxies and NVDA Lead
Analysis
Friday's tape was dominated by a policy repricing after a strong jobs report, with 162,000 positions added, and US equity indexes finished in the red as the Dow sank (Investor's Business Daily). With the labor print firm, odds of a September Fed rate increase surged — notable under new Fed Chair Kevin Warsh, who took over in January 2026 promising a policy "regime change" to defeat inflation — and prediction-market traders pushed inflation odds toward 100% ahead of the next price print. The rate hit fell hardest on long-duration growth: Netflix (NFLX) fell 4% as rate repricing pressured its multiple, Disney (DIS) dipped while Warner Bros. Discovery (WBD) sat tight, and JPMorgan (JPM) fell even as the 162,000 jobs revived the higher-rates case. Conviction risk names still cut through the macro overhang. Crypto proxies led the gainers: MSTR +17.56% to $144.82 on 45.2M shares, HOOD +16.57% to $124.72, SNOW +16.55% to $356.47, CIFR +14.43%, RIOT +13.44%, and MARA +10.79% to $11.60, with BTBT +17.27% rounding out the top of the board. The AI complex held firm: NVDA was the session's most-traded name, +1.80% to $228.45 on roughly 134.7M shares and on track for a more than two-month high, with an analyst calling the $12.9B Hugging Face deal "strategically valuable" and a prominent economist describing Nvidia as the "buyer of last resort" backstopping the AI boom. Intel (INTC) popped +1.80% to $91.67, Tesla (TSLA) added 5.42% to $376.37 after its Cybercab launch event, and Oracle (ORCL) traded up on OpenAI buzz despite RBC warnings that successive layoffs funding its AI infrastructure buildout carry execution risk. Beneath the indices, earnings-season color and single-stock moves were violently two-sided. Salesforce (CRM) showed the AI inflection with Agentforce and Data 360 ARR growth above 200%, Adobe (ADBE) named a new CEO as AI fears persist ahead of its report, Deutsche Bank said Linde (LIN) is poised to resume 10%-plus EPS growth in 2027, and Merck (MRK) pitched the first oral PCSK9 cholesterol pill, while UnitedHealth (UNH) fell as 30% of approval barriers vanished. On the other side, TPC gapped down 80.96% to $16.71 on an unusually thin 131,770-share volume, RARE shed 44.03% to $14.85, MEI dropped 15.36% to $15.32, METC lost 14.30% to $12.35, and CIEN fell 10.36% to $317.46. Technicals confirm the narrow construct: across 2,594 symbols analyzed, only 6 bullish signals registered against 43 bearish, with oversold-momentum flags on SION, TPC, EYPT and ALMS and overbought warnings on TEAM ($194.68) and MRNA ($148.87).
Highlights
- Crypto proxies led the gainers against the macro overhang: MSTR +17.56% to $144.82, HOOD +16.57% to $124.72, SNOW +16.55% to $356.47, CIFR +14.43%, RIOT +13.44%, MARA +10.79%
- NVDA was the session's most-traded name at +1.80% to $228.45 on ~134.7M shares and is on track for a 2+ month high, with the $12.9B Hugging Face deal called 'strategically valuable'
- TSLA +5.42% to $376.37 after the Cybercab launch event; INTC +1.80% to $91.67; NVDA framed as the AI boom's 'buyer of last resort' backstopping MSFT/GOOG/META capex
Lowlights
- 162,000-jobs report sent September Fed rate-increase odds surging — US equity indexes fell and the Dow sank, with prediction-market inflation odds moving toward 100%
- Rate repricing punished long-duration growth: NFLX -4% on rate repricing, DIS dipped, JPM fell even on the strong labor data; breadth is weak at 6 bullish vs 43 bearish signals across 2,594 symbols
- Single-name carnage: TPC -80.96% to $16.71 (on just 131,770 shares), RARE -44.03% to $14.85, METC -14.30% to $12.35, CIEN -10.36% to $317.46
Bull News
- NVDA on track to hit an over-2-month high; analyst calls the $12.9B Hugging Face deal 'strategically valuable' and a prominent economist says Nvidia is backstopping the AI boom as 'buyer of last resort'
- Salesforce (CRM) grew Agentforce and Data 360 ARR more than 200% — AI finally becoming material to growth; TSLA +5.42% to $376.37 after the Cybercab launch event
- Linde (LIN) poised to resume 10%-plus EPS growth in 2027 (Deutsche Bank); Merck (MRK) eyes the first oral PCSK9 cholesterol pill; ORCL up on OpenAI buzz ahead of Q1 results
Bear News
- 162,000 jobs revived the higher-rates case: JPM fell, September Fed rate-increase odds surged, and inflation odds moved toward 100% ahead of the print
- NFLX -4% as rate repricing pressures long-duration growth (DIS dips, WBD sits tight); RBC says Oracle's layoffs to fund its AI infrastructure buildout carry execution risk
- UnitedHealth (UNH) fell as 30% of approval barriers vanished; overbought flags on TEAM ($194.68) and MRNA ($148.87) cap the bullish set of just 6 signals
Friday set up a barbell market: the rate-hike repricing (162,000 jobs, September Fed increase odds surging, inflation odds drifting toward 100% under Chair Warsh's inflation-first mandate) is pressuring long-duration names (NFLX -4%, JPM down), yet conviction risk is still concentrating in crypto proxies (MSTR +17.56%, HOOD +16.57%, CIFR +14.43%) and the AI bedrock (NVDA +1.80% to $228.45 on 134.7M shares toward a 2-month high, SNOW +16.55% to $356.47, TSLA +5.42% to $376.37). Breadth is the tell — 6 bullish vs 43 bearish signals across 2,594 symbols, with overbought flags on TEAM ($194.68) and MRNA ($148.87) — so the constructive play favors earnings-proven names (CRM's 200%+ ARR growth, ORCL's Stargate focus) and the oversold momentum list (SION, EYPT, ALMS) while steering clear of the carnage list (TPC -80.96%, RARE -44.03%, METC -14.30%); the inflation print is the next catalyst, and in this regime any hot read keeps September hikes firmly in play.